Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Has results × Methylphenidate × Clear all

Phase

Phase 3 3 Phase 2 2 Phase NA 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Fatigue 1

Interventions

pembrolizumab 85 Cyclophosphamide 56 Paclitaxel 53 Cisplatin 52 Carboplatin 44 Gemcitabine 41 Radiotherapy 37 Nivolumab 34 Docetaxel 33 Capecitabine 31 fludarabine 30 Pemetrexed 25 Dexamethasone 25 Radiation 22 fludarabine phosphate 21 Lenalidomide 21 Doxorubicin 21 Vorinostat 20 Bevacizumab 20 Rituximab 18 Vincristine 17 Ipilimumab 17 Azacitidine 17 Oxaliplatin 16 Irinotecan 16 atezolizumab 15 Temozolomide 15 Fluorouracil 15 Etoposide 15 Cytarabine 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01164956 2019-04-26

Methylphenidate for Cancer-Related Fatigue

Dana-Farber Cancer Institute

Phase 1 Terminated

3 enrolled 7 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡